The FDA approves Flamel's (FLML) cholinesterase inhibitor Bloxiverz which reverses neuromuscular...

|About: Flamel Technologies S.A. (FLML)|By:, SA News Editor

The FDA approves Flamel's (FLML) cholinesterase inhibitor Bloxiverz which reverses neuromuscular blockade produced during surgery. (PR)